Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

Eligo Bioscience

Main focus: Treatment of bacterial infections

Company stage: Pre-clinical

Diseases (gene editing): Undisclosed

Genome editing tool: CRISPR-Cas

Funding stage: Private

Location: Paris, France


Gene editing partnerships: GlaxoSmithKline

Eligo Biosciences seeks to perform precision editing of the human microbiome in order to treat infectious diseases. The company develops engineered phages that deliver CRISPR-Cas systems to pathogenic bacteria. The company has not yet disclosed its lead development programmes, but announced a research and option agreement with GlaxoSmithKline to advance new development candidates from its technology platform.


HashtagEligo Bioscience

Company: Eligo Bioscience
Jobs, banner ads, webinars, sponsored content...
Search CRISPR Medicine